City
Epaper

COVID-19 Vaccine: Bombay High Court refuses to hear plea on differential pricing of vaccines

By Lokmat English Desk | Updated: April 29, 2021 16:50 IST

The third phase of corona vaccination across the country is starting from May 1. Emphasis is being placed on ...

Open in App

The third phase of corona vaccination across the country is starting from May 1. Emphasis is being placed on corona vaccination against the backdrop of increasing covid cases. The third phase of corona vaccination is very important and everyone above the age of 18 will be vaccinated. Against this backdrop, a petition was filed in the Bombay High Court seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of ₹150 (plus GST) per dose. However, the court has refused to hear the petition.

The Serum Institute recently announced the price of the corona vaccine. After that the price of its vaccine was reduced from ₹400 to ₹300 per dose to the State governments. The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan in the Bombay High Court seeking an order to provide corona vaccine at the same rate of Rs 150 per dose across the country. However, High Court Chief Justice Dipankar Dutta has refused to hear the petition and advised the petitioners to approach the Supreme Court.

The Supreme Court has already made it clear that issues that have pan-India effect will be dealt with by them and pricing is a phenomenon applicable all over India. The Supreme Court has taken notice even before you filed the petition. You can appeal to them, explained Justice Dipankar Dutta.We have an idea of ​​the situation and are constantly telling the Central and State Governments to ensure that people get better treatment, ”the High Court said in a statement.

Meanwhile, the country is focusing on vaccination and from May 1, everyone above the age of 18 will be vaccinated. However, vaccination will not start in Maharashtra, state health minister Rajesh Tope said after a cabinet meeting on Wednesday. Tope added that the decision was made because of the low availability of vaccine doses.

Tags: Bombay High CourtSerum institue of indiaCoronavirus VaccineCovid-19CoronavirusCovishieldCovaxin
Open in App

Related Stories

MumbaiMumbai Pollution: Bombay High Court Calls Clean Air a Fundamental Right, Slams BMC Over Kanjurmarg Stench

MaharashtraMaharashtra: Bombay High Court Suspends Sentence of NCP Leader Manikrao Kokate, Grants Bail in 1995 Cheating and Forgery Case

MumbaiBomb Threats Issued to Bombay High Court and Magistrate Courts in Andheri, Bandra and Esplanade; Search Underway

MumbaiMumbai: Man Attempts Self-Immolation Outside Bombay High Court, Suffers Severe Burns

MaharashtraBombay High Court Recruitment 2025: Notification for 2,381 Vacancies for Clerk, Driver, Peon and Steno; Application From December 15

Maharashtra Realted Stories

MumbaiMumbai Customs Seize 24 Kg Hydroponic Weed Worth Rs 24 Crore at Airport; 9 Passengers Arrested

MumbaiMumbai: Woman Brutally Murdered Over Loan Dispute in Ghatkopar; Neighbouring Auto-Rickshaw Driver Arrested

MumbaiBMC Elections 2026: AAP Releases ‘Kejriwalchi Guarantee’ Manifesto, Promises Free Water, Power, Education and Healthcare

MumbaiNew Year 2026: Mumbai Police Tighten Security as City Gears Up for Celebrations, Over 17,000 Police Personnel Deployed

MumbaiMumbai New Year Celebrations 2026: Siddhivinayak Temple Announces Special Darshan Timings For January 1 - Check Details